EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Switching from Vitamin K Antagonists to Direct Oral Anticoagulants in Frail Elderly Patients with Atrial Fibrillation: Systematic Review and Meta-Analysis

Paschalis Karakasis iD, Ricardo Gómez-Huelgas iD, Stylianos Tzeis, Konstantinos Vlachos iD, Konstantinos C Siontis, Alberto M Marra iD, Konstantinos Pamporis iD, Antonios P Antoniadis iD, Eleftheria Lefkou, Valentin A Kokorin, Dimitrios Patoulias iD, Nikolaos Fragakis iD

Medical Sciences · 25.08.2026 · 14 (5) · 516

DOI: 10.3390/medsci14050516 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Medical Sciences, online erschienen am 25.08.2026. Verfasst von Paschalis Karakasis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital, 546 42 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Drug Substitution, Vitamin K. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frailty complicates anticoagulation management in older patients with atrial fibrillation (AF), particularly when long-term vitamin K antagonist (VKA) therapy is already established. Whether switching to a direct oral anticoagulant (DOAC) improves outcomes in this setting remains uncertain, and guideline recommendations are limited. We performed a systematic review and meta-analysis comparing outcomes of VKA-to-DOAC switching versus VKA continuation in frail elderly patients with AF.

Methods

MEDLINE, Scopus, and the Cochrane Library were systematically searched from inception through 4 April 2026. Studies enrolling frail elderly patients with AF receiving VKA therapy and directly comparing switching to a DOAC versus continued VKA treatment were eligible. The primary outcome was a composite of stroke/systemic embolism, major bleeding, or all-cause mortality. Adjusted hazard ratios (HRs) were pooled using three-level random-effects models.

Results

Four studies (five treatment comparisons) comprising 57,099 patients were included. Overall, switching from VKA to DOAC therapy was not associated with a significant difference in the composite outcome compared with continued VKA treatment (HR 1.18, 95% CI 0.84–1.67). No significant differences were observed for major bleeding (HR 1.13, 95% CI 0.80–1.60), thromboembolism (HR 1.03, 95% CI 0.63–1.68), or all-cause mortality (HR 0.95, 95% CI 0.77–1.16). In analyses restricted to randomized trials, results remained neutral across all outcomes.

Conclusion

In frail elderly patients with AF receiving VKA therapy, switching to a DOAC was not associated with significant reductions in thromboembolism, major bleeding, mortality, or the composite outcome compared with continued VKA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAtrial FibrillationDrug SubstitutionVitamin KAgedAged, 80 and overHumansAdministration, OralFrail ElderlyHemorrhageStroke

Stichwörter der Autor:innen

anticoagulationatrial fibrillationdirect oral anticoagulantselderlyfrailtymajor bleedingmortalityswitchingthromboembolismvitamin K antagonistswarfarin

Substanzen

AnticoagulantsVitamin K

Autor:innen und Institutionen

  • Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital, 546 42 Thessaloniki, Greece.
  • Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), 29010 Malaga, Spain.
  • Department of Cardiology, Mitera Hospital, 6 Erythrou Stavrou Str., 151 23 Marousi, Greece.
  • Electrophysiology and Heart Modeling Institute, IHU Liryc, Fondation Bordeaux Université, Université de Bordeaux, INSERM U1045, 33604 Pessac, France.
  • Cardiac Arrhythmia Department, INSERM U1045, CHU de Bordeaux, 33604 Pessac, France.
  • Electrophysiology Department, Hygeia Hospital, 151 23 Athens, Greece.

ORCID-Profile: Paschalis Karakasis, Ricardo Gómez-Huelgas, Konstantinos Vlachos, Alberto M Marra, Konstantinos Pamporis, Antonios P Antoniadis, Dimitrios Patoulias, Nikolaos Fragakis

Zitieren

APA

Karakasis, P., Gómez-Huelgas, R., Tzeis, S., Vlachos, K., Siontis, K. C., Marra, A. M., Pamporis, K., Antoniadis, A. P., Lefkou, E., Kokorin, V. A., Patoulias, D., & Fragakis, N. (2026). Switching from Vitamin K Antagonists to Direct Oral Anticoagulants in Frail Elderly Patients with Atrial Fibrillation: Systematic Review and Meta-Analysis. Medical Sciences, 14(5), 516. https://doi.org/10.3390/medsci14050516

Vancouver

Karakasis P, Gómez-Huelgas R, Tzeis S, Vlachos K, Siontis KC, Marra AM, et al. Switching from Vitamin K Antagonists to Direct Oral Anticoagulants in Frail Elderly Patients with Atrial Fibrillation: Systematic Review and Meta-Analysis. Medical Sciences. 2026;14(5):516. doi:10.3390/medsci14050516

BibTeX
@article{Karakasis2026,
  author = {Karakasis, Paschalis and Gómez-Huelgas, Ricardo and Tzeis, Stylianos and Vlachos, Konstantinos and Siontis, Konstantinos C and Marra, Alberto M and Pamporis, Konstantinos and Antoniadis, Antonios P and Lefkou, Eleftheria and Kokorin, Valentin A and Patoulias, Dimitrios and Fragakis, Nikolaos},
  title = {Switching from Vitamin K Antagonists to Direct Oral Anticoagulants in Frail Elderly Patients with Atrial Fibrillation: Systematic Review and Meta-Analysis},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {516},
  doi = {10.3390/medsci14050516}
}
Kostenlos starten →